H. Lundbeck A/S (Lundbeck) has announced results from FOCUS, a new study(1) showing that Brintellix (vortioxetine) 10 mg and 20 mg, met its primary endpoint in demonstrating superiority versus placebo ...
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. This sheet allows one to record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback